Home / Immunoglobulins, Normal Human, for Extravascular Adm. / Italy
IT ATC J06BA01 · updated 2 Nov 2026
Immunoglobulins, Normal Human, for Extravascular Adm. shortage in Italy
Is there an Immunoglobulins, Normal Human, for Extravascular Adm. shortage in Italy?
Yes. As of 2 Nov 2026, 14 Immunoglobulins, Normal Human, for Extravascular Adm. products are reported short in Italy, the first since 16 Jun 2021. The company estimate for the return is 31 Dec 2026. Main reason: increased demand.
Also short in Austria, Czechia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | HYQVIA discontinuation | BAXALTA INNOVATIONS GMBH | 16 Jun 2021 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | HYQVIA discontinuation | BAXALTA INNOVATIONS GMBH | 1 Oct 2021 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | HYQVIA discontinuation | BAXALTA INNOVATIONS GMBH | 8 Nov 2021 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | HYQVIA discontinuation | BAXALTA INNOVATIONS GMBH | 15 Dec 2021 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | HYQVIA discontinuation | BAXALTA INNOVATIONS GMBH | 31 Oct 2022 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | CUVITRU | BAXALTA INNOVATIONS GMBH | 1 Apr 2025 | not given | Distribution or logistics Ridotta disponibilità per forniture discontinue: distribuzione contingentata |
| IT | CUVITRU | BAXALTA INNOVATIONS GMBH | 1 Apr 2025 | not given | Distribution or logistics Ridotta disponibilità per forniture discontinue: distribuzione contingentata |
| IT | CUVITRU | BAXALTA INNOVATIONS GMBH | 1 Apr 2025 | not given | Distribution or logistics Ridotta disponibilità per forniture discontinue: distribuzione contingentata |
| IT | CUTAQUIG discontinuation | OCTAPHARMA ITALY S.P.A. | 10 Mar 2026 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | CUTAQUIG discontinuation | OCTAPHARMA ITALY S.P.A. | 10 Mar 2026 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | CUTAQUIG discontinuation | OCTAPHARMA ITALY S.P.A. | 10 Mar 2026 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | CUTAQUIG discontinuation | OCTAPHARMA ITALY S.P.A. | 10 Mar 2026 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | HIZENTRA discontinuation | CSL BEHRING GMBH | 6 Jul 2026 | 31 Dec 2026 | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | HIZENTRA discontinuation | CSL BEHRING GMBH | 6 Jul 2026 | 31 Dec 2026 | Increased demand Elevata richiesta: distribuzione contingentata |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.